The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4–23) in DOCA-salt hypertensive rats

This publication has 16 references indexed in Scilit:

• Drugs Inhibiting the Metabolism and Inactivation of Atrial Natriuretic Factor: Pharmacological Actions and Therapeutic Implications
  Cardiovascular Drug Reviews, 1990
• Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
  Hypertension, 1990
• UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic
  Biochemical and Biophysical Research Communications, 1989
• The Biochemical Pharmacology of Atrial Peptides
  Annual Review of Pharmacology and Toxicology, 1989
• Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo
  Molecular and Cellular Endocrinology, 1989
• (Na + K + 2Cl) cotransport in cultured embryonic chick heart cells
  American Journal of Physiology-Cell Physiology, 1988
• Role of endopeptidase‐24.11 in the inactivation of atrial natriuretic peptide
  FEBS Letters, 1988
• Physiological Role of Silent Receptors of Atrial Natriuretic Factor
  Science, 1987
• Disappearance of atrial natriuretic factor from circulation in the rat
  Peptides, 1986
• Depressor and natriuretic activities of several atrial peptides
  Regulatory Peptides, 1984